Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 210,000,570 papers from all fields of science
Search
Sign In
Create Free Account
olanzapine 15 MG Disintegrating Oral Tablet
Known as:
OLANZAPINE 15MG,TAB RAPID DISINTEGRATING [VA Product]
, OLANZAPINE 15 mg ORAL TABLET, ORALLY DISINTEGRATING [Olanzapine]
, Olanzapine 15 mg ORAL TABLET, ORALLY DISINTEGRATING
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
33 relations
Adrenergic alpha-Antagonists [MoA]
Antipsychotic Agents
Aspartame
Benzyl Alcohol
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Application of plasma levels of olanzapine and N-desmethyl-olanzapine to monitor metabolic parameters in patients with schizophrenia
Mong-Liang Lu
,
Chun-Hsin Chen
,
P. Kuo
,
Chia-Hui Lin
,
Tzu-Hua Wu
Schizophrenia Research
2017
Corpus ID: 3986196
2014
2014
Long-term functional improvements in the 2-year treatment of schizophrenia outpatients with olanzapine long-acting injection
H. Ascher-Svanum
,
D. Novick
,
J. Haro
,
J. Bertsch
,
D. McDonnell
,
H. Detke
Neuropsychiatric Disease and Treatment
2014
Corpus ID: 10521943
Background Little is known about the long-term changes in the functioning of schizophrenia patients receiving maintenance therapy…
Expand
2014
2014
Incidences of extrapyramidal symptoms in patients with schizophrenia after treatment with long-acting injection (depot) or oral formulations of olanzapine.
A. Hill
,
Bin Sun
,
D. McDonnell
Clinical Schizophrenia and Related Psychoses
2014
Corpus ID: 207646716
BACKGROUND The incidence of extrapyramidal symptoms (EPS) has been shown to be generally low among patients with schizophrenia…
Expand
2013
2013
Predictors of psychiatric hospitalization during 6 months of maintenance treatment with olanzapine long-acting injection: post hoc analysis of a randomized, double-blind study
H. Ascher-Svanum
,
D. Novick
,
J. Haro
,
J. Bertsch
,
D. McDonnell
,
H. Detke
BMC Psychiatry
2013
Corpus ID: 732587
BackgroundHospitalization is a costly and distressing event associated with relapse during schizophrenia treatment. No…
Expand
Review
2013
Review
2013
Author ' s response to reviews Title : Predictors of psychiatric hospitalization during 6 months of maintenance treatment with olanzapine long-acting injection : post hoc analysis of a randomized…
D. Novick
,
J. Haro
,
J. Bertsch
2013
Corpus ID: 6728634
Background: Hospitalization is a costly and distressing event associated with relapse during schizophrenia treatment. No…
Expand
Review
2012
Review
2012
Effects of olanzapine long-acting injection on levels of functioning among acutely ill patients with schizophrenia
M. Witte
,
M. Case
,
K. Schuh
,
H. Ascher-Svanum
Current Medical Research and Opinion
2012
Corpus ID: 40881571
Abstract Objective: To assess the effects of olanzapine long-acting injection (olanzapine-LAI) on levels of functioning in…
Expand
Review
2010
Review
2010
Long-acting injectable antipsychotics: focus on olanzapine pamoate
J. Lindenmayer
Neuropsychiatric Disease and Treatment
2010
Corpus ID: 1769683
Medication non-adherence in patients with schizophrenia continues to be a significant problem and threatens successful treatment…
Expand
Highly Cited
2004
Highly Cited
2004
A study of matrix effects on an LC/MS/MS assay for olanzapine and desmethyl olanzapine.
C. Chin
,
Z. Zhang
,
H. Karnes
Journal of Pharmaceutical and Biomedical Analysis
2004
Corpus ID: 31048105
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE